… the cellular and molecular mechanisms involved in the cardioprotective response can lead
to … response also can be stimulated by brief cycles of I/R at a remote non-cardiac site (remote …

… inaccessible sites. Still, its therapeutic role is difficult to study as EPC could not be the only
cell type … , and manipulate exerkines to harness their full power to achieve cardioprotection. …

… to modulate endogenous antioxidant systems. Activation of Nrf2 reduces cell damage while
… Metformin can activate AMPK by phosphorylation of the key regulatory site (Thr-172) on the …

… models provides cardioprotection at the level of the cardiomyocyte by increasing cell viability
[52], … Harnessing the potential angiogenic capacity of FGFs for cardiovascular treatment has …

… of the injected cells as cardioprotective and cardio-reparative … and reach target sites far from
their primary release site. These … Harnessing the cellular and molecular basis of this cell-to-…

… Together, these enzymes form key nodes to produce and regulate endogenous H 2 S production.
… While few, if any, studies have proven a cardioprotective role for CBS, mutations in this …

… state of the art regarding novel cardioprotective endogenous peptides, such as … harnessing
their full cardioprotective power. We also explore targeting of exosomes as a cardioprotective …

… Endogenous opioids such as enkephalin likely activate one or more … Harnessing the
cardioprotective potential of these, or yet-to-… Endogenous opioid-induced cardioprotection is …

… The aim of harnessing or exploiting the beneficial effects of … The cardioprotective effects
of Eya2 are considered to be … of the endogenous cellular ROS scavenging mechanisms (ie, …

… This review will highlight cardioprotective pathways activated in … of Akt is necessary to
harness its protective capacity. … Thus, resident CFs may serve as an endogenous source of cells …